INTERNATIONAL PATENT: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED FILES APPLICATION FOR "PROCESS OF MANUFACTURE OF P2X3 ANTAGONISTS INCLUDING CAMLIPIXANT"

GENEVA, June 23 -- GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED (GSK Medicines Research CentreGunnels Wood RoadStevenage SG1 2NY) filed a patent application (PCT/EP2024/085943) for "PROCESS OF MANUFACTURE OF P2X3 ANTAGONISTS INCLUDING CAMLIPIXANT" on Dec 12, 2024. With publication no. WO/2025/125445, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHEN, Heng (GSK1250 South Collegeville RoadCollegeville, Pennsylvania 19426), HIGGINS, Tyler Frank (GSK1250 South Collegeville RoadCollegeville, Pennsylvania 19426), NIL...